Imv Inc: What if the promise of cancer vaccines was finally realized?
IMV Inc. is a clinical-stage immuno-oncology company based in Dartmouth, NS and Boston, MA. IMV is advancing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers without the well-known toxicities typically associated with cancer therapies. By generating educated immune cells that can elicit a specific, robust and sustained…